|
|
||||||||


1 Flavivirology Laboratory, Department of Microbiology, 5 Science Drive 2, National University of Singapore, Singapore 117597, Singapore
2 School of Biological Sciences, Nanyang Technological University, 1, Nanyang Walk, Singapore 637616, Singapore
Correspondence
M.-L. Ng
micngml{at}nus.edu.sg
The envelope glycoprotein located at the outermost surface of the flavivirus particle mediates entry of virus into host cells. In this study, the involvement of domain III of West Nile virus (WNV-DIII) envelope protein in binding to host cell surface was investigated. WNV-DIII was first expressed as a recombinant protein and purified after a solubilization and refolding procedure. The refolded WNV-DIII protein displays a content of
-sheets consistent with known homologous structures of other flavivirus envelope DIII, shown by using circular dichroism analysis. Purified recombinant WNV-DIII protein was able to inhibit WNV entry into Vero cells and C6/36 mosquito cells. Recombinant WNV-DIII only partially blocked the entry of dengue-2 (Den 2) virus into Vero cells. However, entry of Den 2 virus into C6/36 was blocked effectively by recombinant WNV-DIII. Murine polyclonal serum produced against recombinant WNV-DIII protein inhibited infection with WNV and to a much lesser extent with Den 2 virus, as demonstrated by plaque neutralization assays. Together these results provided strong evidence that immunoglobulin-like DIII of WNV envelope protein is responsible for binding to receptor on the surface of host cells. The data also suggest that similar attachment molecule(s) or receptor(s) were used by WNV and Den 2 virus for entry into C6/36 mosquito cells.
Both J. J. H. Chu and R. Rajamanonmani contributed equally to this work.
This article has been cited by other articles:
![]() |
M. R. Vogt, B. Moesker, J. Goudsmit, M. Jongeneelen, S. K. Austin, T. Oliphant, S. Nelson, T. C. Pierson, J. Wilschut, M. Throsby, et al. Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step J. Virol., July 1, 2009; 83(13): 6494 - 6507. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rajamanonmani, C. Nkenfou, P. Clancy, Y. H. Yau, S. G. Shochat, S. Sukupolvi-Petty, W. Schul, M. S. Diamond, S. G. Vasudevan, and J. Lescar On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes J. Gen. Virol., April 1, 2009; 90(4): 799 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Gromowski, N. D. Barrett, and A. D. T. Barrett Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus J. Virol., September 1, 2008; 82(17): 8828 - 8837. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oliphant, G. E. Nybakken, S. K. Austin, Q. Xu, J. Bramson, M. Loeb, M. Throsby, D. H. Fremont, T. C. Pierson, and M. S. Diamond Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus J. Virol., November 1, 2007; 81(21): 11828 - 11839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. J. Chu, C.-C. S. Chiang, and M.-L. Ng Immunization of Flavivirus West Nile Recombinant Envelope Domain III Protein Induced Specific Immune Response and Protection against West Nile Virus Infection J. Immunol., March 1, 2007; 178(5): 2699 - 2705. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Choi, Y.-J. Ko, J.-J. Nah, Y.-J. Kim, S.-Y. Kang, K.-J. Yoon, and Y.-S. Joo Monoclonal Antibody-Based Competitive Enzyme-Linked Immunosorbent Assay for Detecting and Quantifying West Nile Virus-Neutralizing Antibodies in Horse Sera Clin. Vaccine Immunol., February 1, 2007; 14(2): 134 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oliphant, G. E. Nybakken, M. Engle, Q. Xu, C. A. Nelson, S. Sukupolvi-Petty, A. Marri, B.-E. Lachmi, U. Olshevsky, D. H. Fremont, et al. Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein J. Virol., December 15, 2006; 80(24): 12149 - 12159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Samuel and M. S. Diamond Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion J. Virol., October 1, 2006; 80(19): 9349 - 9360. [Full Text] [PDF] |
||||
![]() |
B. Kaufmann, G. E. Nybakken, P. R. Chipman, W. Zhang, M. S. Diamond, D. H. Fremont, R. J. Kuhn, and M. G. Rossmann West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody PNAS, August 15, 2006; 103(33): 12400 - 12404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W.-M. Lee, J. J.-H. Chu, and M.-L. Ng Quantifying the Specific Binding between West Nile Virus Envelope Domain III Protein and the Cellular Receptor {alpha}Vbeta3 Integrin J. Biol. Chem., January 20, 2006; 281(3): 1352 - 1360. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |